Blue Diamond Ventures Inc (BLDV)

[JPS02]

BLDV + Israel + Eltron Research + Global Market for Cannabis: What we know so far

1. Facebook - 3/20/17: BLDV discloses that Joshua B. Alper, CEO of Blue Diamond Ventures, Inc. is attending the 2017 CannaTech event on March 20 - 22, 2017

CannaTech is an annual event hosted in Israel, the heartland of innovation. CannaTech is designed to bring together the world’s most dynamic cannabis professionals for a rare chance to network, kick around conventional thinking about medical cannabis.

CannaTech showcases the full spectrum of global industry leaders, spanning the fields of science, research, finance, medicine, government policy, tech innovation, agriculture & entrepreneurship, at one outstanding event with a singular focus on cannabis and all the opportunity that surrounds it.

- Note the key highlights and how they are trying to describe the caliber of this event and in turn BLDV's intentions of attending the event
Here are the highlights from Cannatech 2017:

Source: https://www.facebook.com/108751362804882/photos/a.108785682801450.1073741827.108751362804882/411598989186783/?type=3&permPage=1


2. 4/26/17 PR and 5/3/17 Facebook: BLDV discloses that Jonathan Alper, Manager of Blue Diamond Consulting LLC and Principle of Alper & Associates Consulting, is traveling to Israel on Thursday, May 5th as an official representative of BLDV.

Mr. Alper will be meeting with government officials, and current & prospective clients to fully understand the logistics of importing/exporting cannabis products to and from Israel.

“I have done business in Israel for over 40 years,” said Alper “Regulatory Compliance is key, we will now start to coordinate our efforts with Health Canada, and the Israeli Health Ministries, Cannabis Unit”

- Notice how: i) There is explicit disclosure of the purpose of Jonathan's trip to Israel and how it relates to importing/exporting.

ii) The disclosure is not to discuss possibilities, but to discuss logistics and starting coordination thereby possibly indicating at how far they could be in the process

iii) There is explicit disclosure that Jonathan is travelling to Israel as an official representative. Official representatives are normally authorized to transact and engage in on behalf of who they represent, i.e. BLDV:

Sources: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures-Inc--Outlines-Operational-Strategies-for-2017?id=157095&b=y

https://www.facebook.com/permalink.php?story_fbid=433462800333735&id=108751362804882

State of Israel - Ministry of Health: Medical Cannabis Unit

The Medical Cannabis Unit is the authorized body in the Ministry of Health to issue patients with permits to use cannabis for medical purposes, in accordance with the Procedures that have been set (link to Procedure 106), to assess authorization and to issue appropriate permits to those engaged in the field of cannabis and to investigators and various research bodies that wish to carry out studies of cannabis and cannabinoids.

Source: https://www.health.gov.il/English/MinistryUnits/HealthDivision/cannabis/Pages/default.aspx


3. 4/26/17 PR and 5/3/17 Facebook: BLDV discloses that on May 28th, 2017, Joshua B. Alper CEO of Blue Diamond will be returning to Israel to conduct the next round of meetings on the Technology & Science side.

“We have the MJ Daily on May 16th, the LIFT Show in Toronto May 26th, and then back to Israel on May 28th, “says Josh “The timing could not be better”

- Note the timing of the trips from #2 to #3 and then how it falls after the Lift Show. Also, the post explicitly states that it is the next round of meetings. I think this is another possible indication of how far they could possibly be in the process.

Sources: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures-Inc--Outlines-Operational-Strategies-for-2017?id=157095&b=y

https://www.facebook.com/permalink.php?story_fbid=433462800333735&id=108751362804882


4. 4/20/17 PR: Key excerpts are: i) BLDV has entered into a Joint Development Agreement with Alternative Medical Solutions Inc., to import & export Targeted Medicinal Cannabis Products and Advanced Cannabis Technologies, to and from Canada.

- I do not think BLDV and AMS would enter into a JV if they were not possibly sure of the road they are taking with each and into other countries

ii) The recent CannaTech Conference in Israel provided the forum to secure the initial agreements required to pursue this effort

- Further to 4.i above, I think BLDV could be telling us that they have agreements in Israel to support/demand the other side of the JV with AMS

iii) This new effort will ensure that AMS, when licensed, will be a Global Project, with their products being available worldwide and with access to the ingredients and technology that will continue to make AMS a leader in the Canadian market."

- Further to 4.ii above, I think BLDV could be telling us that they will equip AMS with the necessary ingredients and technologies (hint: Israel) to become a player in the Global and Canadian market, thereby solidifying the need of both AMS and Israel Cannabis for each other

iv) "We are excited to launch this effort with BLDV," said Joseph Groleau, VP Business Development for AMS. "With the specialized products and technologies coming into Canada from Israel, and access to global markets with our finished products, we see this as a separate profit center that could even outgrow our efforts in cultivation."

- Further to 4.iii above, I think AMS could be trying to highlight the significance of the JV and how their ability to access and export global markets might be bigger than cultivation

v) Canada will be the home to the new joint venture, and the first market focus will be to bring Israeli Cannabis products and technology to Canada. "AMS is the perfect partner for this project," said Joshua B. Alper, CEO of Blue Diamond Ventures, Inc.

- Notice how the CEO BLDV is re-emphasizing the importance of the JV to bring Israeli products and technology to Canada but also indicating it will be the first market focus. It is possible that BLDV is planning to export to other markets after they succeed in the Israeli and Canadian markets in order to possibly become a Global Exporter.

Source: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures--Inc--launches-International-Cannabis-Project-with-AMS-Canada?id=156512&b=y


5. 5/10/17 Facebook: BLDV confirms that Jonathan Alper, Blue Diamond Director has been in Israel for the past few days conducting meetings on behalf of BLDV.

- Good to the see follow through on #2 that the trip took place in the same capacity BLDV indicated Jonathan would.

Source: https://www.facebook.com/permalink.php?story_fbid=436280033385345&id=108751362804882

Check out this CNN documentary on Israel's Cannabis Research and the science behind the research:

Israel : World capital of Cannabis Research

6. 5/26/17 PR: Blue Diamond Ventures Inc. announces a strategic partnership with Eltron Research & Development of Boulder Colorado, the creators of the ImPAAct™ Peracetic Acid Generator : Eltron R&D specializes in Material Sciences and adds considerable strength to BLDV on multiple levels.

- The key disclosures in this PR are that:

i) BLDV has been named the Representative of Eltron for Israel and Canada and will be facilitating the licensing of the PAA technology in those countries.

ii) Blue Diamond Ventures will also use the expertise of Eltron to help achieve the goal of bringing Targeted Cannabis Therapies from Israel to the USA and to Canada as part of the previously announced venture with AMS of Hanover, Canada.

http://www.eltronresearch.com

- Eltron's technology includes: IMPAACT™ Generator

The ImPAAct reactor from Eltron Water Systems is a patent-pending product to meet your disinfection, bleaching, or chemical oxidation needs. ImPAAct is an onsite reactor that quickly generates peracetic acid (PAA) at concentrations up to 3.5% from concentrated feedstock chemicals. The ImPAAct reactor also has the ability to blend hydrogen peroxide, sulfuric acid, and acetic acid to match the chemistry of equilibrium PAA and the ability for pH adjustment. The ImPAAct works with process streams that have a broad pH range and at temperatures less than 55°C.

Sources: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures-Inc--announces-Strategic-Partnership?id=160232&b=y

https://www.facebook.com/permalink.php?story_fbid=443162249363790&id=108751362804882


7. 6/12/17 PR: Blue Diamond Ventures Inc, Restructures around Israeli Cannabis Opportunities - Key highlights:

i) Blue Diamond has secured multiple opportunities to bring Medical Cannabis products and technology to North America.

- I think this part of the PR is trying to tell us that BLDV has set the stage and has the mechanisms in place to be able to sell products and technology to North America.

ii) Israel has a Startup mentality and companies there understand the need to move quickly said Josh Alper CEO of BLDV, but realistically it is not simple to do business there, we have 40+ years experience with the politics and the culture of the area, combined with the scientific knowledge that is required

- The four bolded words in blue are key in this part, the first three are Josh and Jonathan the fourth is Eltron Research. I think this part of the PR is trying to emphasize the challenges of operating in Israel, yet in #1 they mention that they have secured multiple opportunities, so I think they are trying to tell us they succeeded despite the challenges; i.e. they have the key success factors. Time will tell.

iii) The tradition pharma industry hopes to change the approach to the medical cannabis industry by leveraging clinical trails preformed in Israel, but at the same time the Cannabis plant is changing the industry by achieving real success with less than pharmaceutical grade products.

- I find this part interesting in terms of how often they are mentioning the pharmaceutical industry. Also, notice how the effects of the Cannabis plant on the traditional industry is highlighted. I wonder if they are trying to tell us something about the caliber or size of partnerships they have secured that want in due to the fact that cannabis is changing the industry. Time will tell.

- Finally, remember that Josh told us in the last interview that Israel is the only country in the world that has clinical trials on humans for cannabis. I find it interesting that this is mentioned again in the PR.

iv) Blue Diamond will create a wholly owned subsidiary Blue Diamond Technologies LLC to focus on these opportunities, this unit will be based in Toronto, details of the new structure and specifics on the agreements from Israel will be released during the conference call.

- Key word here is technologies. I think this part is telling us that the technologies they now have access to are significant enough to require a subsidiary on their own. Also, the Toronto headquarters is interestingly close to AMS in Hannover, Ontario. Equally important is that the details on the Israeli agreements will be announced in the Conference call.

Source: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures-Inc--Restructures-around-Israeli-Cannabis-Opportunities-?id=161722&b=y

Go BLDV!